Related Experiment Video
Updated: May 31, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
The Participation of Prolactin in the Immunopathology of Experimental Pulmonary Tuberculosis
Dulce Adriana Mata-Espinosa1, Gabriel Quintero-Bustos1, Daniel Enrique Castillo Baltazar1
1Experimental Pathology Section, Pathology Department, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.
Prolactin boosts immune responses against tuberculosis in mice, enhancing bacterial clearance. Late-stage prolactin treatment reactivates immune protection, reducing bacterial load and tissue damage.
Area of Science:
- Immunology
- Endocrinology
- Infectious Diseases
Background:
- Prolactin (PRL) and its receptor are known for roles in lactation but also influence immune responses.
- These hormones may play a significant role in chronic infectious diseases like tuberculosis (TB).
Purpose of the Study:
- To investigate the role and kinetics of prolactin and its receptor during experimental pulmonary tuberculosis.
- To evaluate the therapeutic potential of prolactin in treating active TB.
Main Methods:
- Mice infected with Mycobacterium tuberculosis (M. tuberculosis) were analyzed for prolactin and receptor gene and protein expression.
- In vitro studies assessed prolactin's effect on macrophage and pneumocyte immune responses.
- Prolactin treatment was administered to mice with progressive pulmonary tuberculosis.
Main Results:
- Prolactin enhanced macrophage phagocytosis and reactive oxygen/nitrogen species production in vitro, reducing bacterial loads.
- In vivo, early infection showed high prolactin and receptor expression in lung immune cells.
- Prolactin administration during late-stage TB significantly reduced bacillary loads.
Conclusions:
- Prolactin and its receptors contribute to immune activation in early pulmonary tuberculosis.
- Prolactin administration can reactivate immune protection during late-stage active disease.
- Further research is warranted to elucidate the underlying mechanisms.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
